NCT00001860View on ClinicalTrials.gov

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 1999

Study Completion Date

July 31, 2002

Conditions
AcromegalyPituitary Neoplasm
Interventions
DRUG

Sandostatin LAR Depot versus transsphenoidal surgery

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00001860 - Sandostatin LAR Depot vs. Surgery for Treating Acromegaly | Biotech Hunter | Biotech Hunter